NUCLEIC ACID LIGANDS SPECIFIC TO IMMUNOGLOBULIN E AND THEIR USE AS ATOPIC DISEASE THERAPEUTICS

The invention discloses aptamers capable of binding to Immunoglobulin E (~IgE~) useful as therapeutics in and diagnostics of atopic disease and/or other diseases or disorders in which IgE has been implicated. The invention further relates to materials and methods for the administration of aptamers c...

Full description

Saved in:
Bibliographic Details
Main Authors WANG, CHUNHUA, CLOAD, SHARON, KURZ, MARKUS, BURMEISTER, PAULA, SAWHNEY, POOJA, MARSH, HAROLD NICHOLAS, LAGASSE, H. A. DANIEL, KEENE, SARA CHESWORTH, DIENER, JOHN L, KEEFE, ANTHONY DOMINIC
Format Patent
LanguageEnglish
French
Published 01.12.2005
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS OR TEST PAPERS THEREFOR
COMPOSITIONS THEREOF
CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES
CULTURE MEDIA
DERIVATIVES THEREOF
ENZYMOLOGY
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
NUCLEIC ACIDS
NUCLEOSIDES
NUCLEOTIDES
ORGANIC CHEMISTRY
PROCESSES OF PREPARING SUCH COMPOSITIONS
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
SUGARS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:The invention discloses aptamers capable of binding to Immunoglobulin E (~IgE~) useful as therapeutics in and diagnostics of atopic disease and/or other diseases or disorders in which IgE has been implicated. The invention further relates to materials and methods for the administration of aptamers capable of binding to IgE.
Bibliography:Application Number: CA20052564311